Related Articles
Multi‑kinase inhibitors and cisplatin for head and neck cancer treatment in vitro
The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance
Reversal of multidrug resistance by the anti‑malaria drug artesunate in the esophageal cancer Eca109/ABCG2 cell line
Elevated expression of Nrf2 mediates multidrug resistance in CD133+ head and neck squamous cell carcinoma stem cells
FaDu cell characteristics induced by multidrug resistance